Cargando…
The role of RICTOR amplification in targeted therapy and drug resistance
The emergence of tyrosine kinase inhibitors (TKIs) has changed the current treatment paradigm and achieved good results in recent decades. However, an increasing number of studies have indicated that the complex network of receptor tyrosine kinase (RTK) co-activation could influence the characterist...
Autores principales: | Zhao, Deze, Jiang, Man, Zhang, Xiaochun, Hou, Helei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011243/ https://www.ncbi.nlm.nih.gov/pubmed/32041519 http://dx.doi.org/10.1186/s10020-020-0146-6 |
Ejemplares similares
-
The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors
por: Hou, Helei, et al.
Publicado: (2019) -
Progress in the treatment of solid tumors with apatinib: a systematic review
por: Zhao, Deze, et al.
Publicado: (2018) -
Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing
por: Sztankovics, Dániel, et al.
Publicado: (2023) -
RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy
por: Jebali, Ahlem, et al.
Publicado: (2021) -
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR
por: Sakre, Nneha, et al.
Publicado: (2016)